G

GW Vitek Co Ltd
KOSDAQ:036180

Watchlist Manager
GW Vitek Co Ltd
KOSDAQ:036180
Watchlist
Price: 1 205 KRW -29.94%
Market Cap: ₩58.4B

Net Margin

-44.7%
Current
Declining
by 9.6%
vs 3-y average of -35.1%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-44.7%
=
Net Income
₩-4.3B
/
Revenue
₩9.6B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-44.7%
=
Net Income
₩-4.3B
/
Revenue
₩9.6B

Peer Comparison

Country Company Market Cap Net
Margin
KR
GW Vitek Co Ltd
KOSDAQ:036180
58.4B KRW
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
223.2B USD
Loading...
US
Danaher Corp
NYSE:DHR
154.9B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
81.3T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
37.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.3B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.3B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
37.4B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.2B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
18.6B EUR
Loading...

Market Distribution

Lower than 90% of companies in Korea
Percentile
10th
Based on 2 632 companies
10th percentile
-44.7%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

GW Vitek Co Ltd
Glance View

GW Vitek CO., LTD. engages in the development, manufacture and sale of antibodies and scientific instruments. The company is headquartered in Seoul, Seoul. The firm operates its business through two business segments. The Scientific Instruments segment mainly distributes scientific equipment and related consumables for experiments and research. The Bio segment mainly develops, manufactures and sells antibodies, new drugs using antibodies and diagnostic kits.

GW Vitek Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-44.7%
=
Net Income
₩-4.3B
/
Revenue
₩9.6B
What is GW Vitek Co Ltd's current Net Margin?

The current Net Margin for GW Vitek Co Ltd is -44.7%, which is below its 3-year median of -35.1%.

How has Net Margin changed over time?

Over the last 3 years, GW Vitek Co Ltd’s Net Margin has decreased from -18.7% to -44.7%. During this period, it reached a low of -52.2% on Sep 30, 2024 and a high of -15.9% on Dec 31, 2022.

Back to Top